Breast Cancer Series I - Personalized 4sCAR-T Immunotherapy

Breakthrough Against the \"King of Childhood Cancer\" - Serial 4sCAR-GD2 T Cell Infusions Significantly Improve Overall Survival of High-Risk Neuroblastoma Patients

Personalized Immune Cell Therapy Prolongs Survival and Improves Quality of Life in Lung Cancer Patients

Overcoming the Challenge of Refractory/Relapsed Multiple Myeloma （MM）- The \"King of Blood Cancer\" - Individualized Multi-Target 4sCAR-T Therapy Brings New Hope

Shenzhen Geno-Immune Medical Institute Ranked Top 2 Globally! Top 10 R&D Institutions for Immune Cell Therapy Products in 2024 Revealed – The US and China Dominate 95% of All Clinical Trials

Gene Therapy Brings Hope to Adrenoleukodystrophy (ALD) Patients

CAR-T Therapy Successfully Targets Colon Cancer, Offering New Hope to Patients​！

From Long-Term Medication Dependency to Cure - The Testimony of Stem Cell Remedy in Hyperthyroidism

The Timing of Immunotherapy Is Crucial! Series One: 5-year Remission in Patients with Colorectal Cancer

New Strategies Targeting Sarcoma with 4SCAR-T